Matricardi, 2000 (43) | Caserta, Italy | 240 atopic cases and 240 non-atopic controls | 17–24 | IgG ELISA | Total IgE | Atopy: | 0.76 (0.47 to 1.24) |
Atopy: logRU >1.2 | | |
Non-atopic: logRU<0 | | |
Bodner, 2000 (55) | Grampion, Scotland | 97 cases and 208 controls | 39–45 | IgG ELISA | Skin & specific IgE tests | Wheeze: | 1.20 (0.70 to 2.20) |
Atopy: weal ⩾3 mm, or any IgE >0.35 IU/ml | Wheeze and asthma: | 0.50 (0.20 to 1.50) |
Self-reported adult-onset wheeze and asthma | Atopy: | 0.90 (0.60 to 1.60) |
Tseng, 2000 (56) | Hong Kong | 90 cases with stable asthma and 97 controls | Mean 43 | IgG ELISA | Current asthma diagnosed by ATS guidelines | Asthma: | 1.55 (0.83 to 2.90) |
Jun, 2005 (57) | Japan | 46 cases with asthma, and 48 healthy controls | Mean 52 | IgG ELISA | Current asthma diagnosed by ATS guidelines | Compared with healthy controls, Asthma: | 1.10 (0.45 to 2.69) |
IgG CagA | | For CagA+, Asthma: | 1.20 (0.39 to 3.69) |